The RELATION study: efficacy and safety of ranibizumab combined with laser photocoagulation treatment versus laser monotherapy in NPDR and PDR patients with diabetic macular oedema

ConclusionThis study showed that ranibizumab plus laser is a valuable treatment option for the management of DME. Patients with DME in PDR might also benefit from combined therapy compared to laser alone.

Source: Acta Ophthalmologica - November 1, 2017 Category: Opthalmology Authors: Gabriele E. Lang, Sandra Liakopoulos, Jessica V ögeler, Claudia Weiß, Georg Spital, Maria‐Andreea Gamulescu, Chris Lohmann, Peter Wiedemann Tags: Original Article Source Type: research